Overexpression of redox factor-1 negatively regulates NO synthesis and apoptosis in LPS-stimulated RAW 264.7 macrophages  by Yoo, Young Hyun et al.
Overexpression of redox factor-1 negatively regulates NO synthesis and
apoptosis in LPS-stimulated RAW 264.7 macrophages
Young Hyun Yooa, Young Jin Limb, Sang Eun Parka, Jong-Min Kima, Young Chul Parka;
aDepartment of Anatomy and Cell Biology, Dong-A University College of Medicine (BK21 Program), Pusan 602-714, South Korea
bDepartment of Parasitology, Dong-A University College of Medicine, Pusan 602-714, South Korea
Received 15 October 2003; revised 10 November 2003; accepted 17 November 2003
First published online 27 November 2003
Edited by Robert Barouki
Abstract Redox factor-1 (Ref-1) is a ubiquitously expressed
protein with proven roles as a modulator of redox-sensitive tran-
scription, and as an endonuclease in the base excision repair
pathway of oxidatively damaged DNA. Although Ref-1 is in-
duced by a variety of oxidative stress and protects cells against
oxidative stress, the function of Ref-1 in regulating nitric oxide
(NO) synthesis has not been elucidated to date. We investigated
the role of Ref-1 in regulating NO synthesis and NO-mediated
apoptosis employing adenoviral-mediated overexpression of Ref-
1 in lipopolysaccharide (LPS)-stimulated macrophage RAW
264.7 cells. LPS treatment produced NO synthesis and NO-
mediated apoptosis. Forced overexpression of Ref-1 suppressed
LPS-stimulated NO synthesis. In parallel with this, Ref-1 also
mitigated alteration of inducible NO synthase expression and
NO-mediated apoptosis. Our ¢ndings suggest that Ref-1 is im-
plicated in protection against cell death resulting from oxidative
stimuli containing NO.
. 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Nitric oxide (NO) is a multifunctional biomolecule involved
in a variety of physiological and pathological processes [1]. In
macrophages, NO contributes to the antimicrobial and tumor-
icidal activities in pathological conditions. In contrast to the
cell protective and anti-in£ammatory e¡ects, overproduction
of NO has been associated with oxidative stress [2,3] and with
the pathophysiology of various diseases such as arthritis, dia-
betes, stroke, septic shock, autoimmune disease, and chronic
in£ammation [4,5]. Moreover, NO mediates reactions with
proteins and nucleic acids, and causes apoptosis of macro-
phages. NO-mediated apoptosis is generally considered to be
mediated by DNA or mitochondrial damage [6]. Because of
the pivotal double-edged role of NO, it is necessary to eluci-
date intracellular molecules involving in regulatory mecha-
nisms for NO synthesis.
Redox factor-1 (Ref-1) is a ubiquitous 37 kDa bifunctional
protein that is transcriptionally upregulated in response to
oxidative stresses [7]. It has the two following important func-
tions: (1) a nuclear reducing factor that promotes the DNA
binding properties of many redox-sensitive transcription fac-
tors that regulate cell growth, di¡erentiation, survival, and
death including AP-1, NF-UB, p53, Egr-1, and c-Myb [8^
11]; and (2) an endonuclease indispensable in the base exci-
sion repair pathway of damaged DNA, which is generated by
oxidative damage [12]. However, the role of Ref-1 in the reg-
ulation of inducible NO synthase (iNOS) and its importance
in macrophage/excess NO-mediated cytotoxicity are not
known. Here we report that Ref-1 regulates bacterial lipopoly-
saccharide (LPS)-induced NO synthesis in RAW 264.7 macro-
phages.
2. Materials and methods
2.1. Materials
LPS (phenol-extracted Salmonella enteritidis), sulfanilamide, N-(1-
naphthyl)-ethylenediamine dihydrochloride, phosphoric acid (H3PO4),
and sodium nitrite (NaNO2) were from Sigma Chemical Co. (St.
Louis, MO, USA). RPMI containing L-arginine (200 mg/l; 1148
WM), Hanks’ balanced salt solution, and other tissue culture reagents
were purchased from Life Technologies (Gaithersburg, MD, USA).
DAF-2 (4,5-diamino£uorescein) was purchased from Alexis Biochem-
icals (Carlsbad, CA, USA). L-NAME was purchased from Calbio-
chem (San Diego, CA, USA). Anti-Ref-1 and anti-iNOS antibodies
were purchased from Santa Cruz Biotechnology (Santa Cruz, CA,
USA).
2.2. Macrophage culture
The murine monocyte/macrophage cell line RAW 264.7 was cul-
tured in 75 cm2 plastic £asks (Falcon-Becton Dickinson Labware,
Franklin Lakes, NJ, USA) and maintained at 37‡C with 5% CO2 in
air atmosphere in RPMI 1640 supplemented with 10% (v/v) heat-in-
activated fetal bovine serum and antibiotics (100 U/ml of penicillin,
100 Wg/ml of streptomycin). For experiments, macrophages were de-
tached by vigorous pipetting and, after centrifugation, incubated with
fresh medium in either 24 well tissue culture plates (5U105 cells/well)
or 35 mm tissue culture dishes (1U106 cells/dish).
2.3. Adenoviruses
The replication-de¢cient adenovirus, AdRef-1, encoding full-length
Ref-1 was constructed through homologous recombination in HEK
293 cells, as described previously [13]. AdDl312 encodes an E1-deleted
adenovirus without a transgene. AdDl-infected cells or uninfected
cells were used as controls in all experiments. Adenoviral stocks
were prepared in HEK 293 cells, puri¢ed on double cesium gradient,
and titered using a standard plaque assay [14]. Infections were carried
out at a multiplicity of infection (MOI) of 50, 150 or 300 for 16 h.
Protein expression and biochemical or functional assays described
below were carried out 28 or 40 h after infection.
2.4. Western blot analysis
Equivalent amounts of total protein were loaded onto 10% sodium
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dodecyl sulfate^polyacrylamide gel electrophoresis (SDS^PAGE). The
gels were transferred to nitrocellulose membrane using an electroblot-
ting apparatus (Bio-Rad, Richmond, CA, USA) and reacted with the
appropriate primary antibody according to standard methods. Bound
immunocomplexes were visualized by ECL reagents (Amersham Phar-
macia Biotech, Piscataway, NJ, USA). L-Actin was used as an internal
control to monitor equal protein sample loading.
2.5. Measurement of nitrite concentration
NO secretion in cultured macrophages was measured by a micro-
plate assay method, as described previously [15]. To measure nitrite
(NO32 ), 100 Wl of macrophage culture supernatant were collected,
mixed with an equal volume of the Griess reagent (1% sulfanil-
amide/0.1% N-(1-naphthyl)-ethylenediamine dihydrochloride/2.5%
H3PO4) and incubated for 10 min at room temperature. Nitrite con-
centration was determined by measuring the absorbance at 540 nm in
an Emax 96 well microtest plate spectrophotometer (Molecular Devi-
ces, Menlo Park, CA, USA). NaNO2 was used for external calibra-
tion. Cell-free medium alone contained 5^8 WM of nitrite; this value
was determined in each experiment and subtracted from the value
obtained for each cell sample.
2.6. Detection of NO production in cells
To measure £uorescence intensity, LPS-stimulated cells were
washed twice with Krebs^Ringer phosphate bu¡er (KRP; 120 mM
NaCl, 4.8 mM KCl, 0.54 mM CaCl2, 1.2 mM MgSO4, 11 mM glu-
cose, and 15.9 mM sodium phosphate, pH 7.2), and then KRP bu¡er
containing 10 WM DAF-2 and 1 mM L-arginine in the presence or
absence of the NO synthase inhibitor L-NAME (1 mM) were added
[16]. After incubation for 1 h, supernatants were collected and the
£uorescence was measured with a £uorescence microplate reader (Ti-
tertek Fluoroscan II, Flow Laboratories, North Ryde, Australia) cali-
brated for excitation at 485 nm and emission at 538 nm.
2.7. Determination of apoptosis and quanti¢cation
Cell suspension was centrifuged onto a clean, fat-free glass slide
with a cytocentrifuge. Cells were ¢xed for 10 min in 4% paraformal-
dehyde and stained in 4 Wg/ml Hoechst 33342 for 30 min at 37‡C. The
samples were observed and photographed under an epi£uorescence
microscope [17]. The number of cells showing condensed or frag-
mented nuclei was determined by a blinded observer from a random
sampling of 250^300 cells per experiment.
2.8. Statistics or reproducibility
Data in ¢gures are the meanPS.D. of at least three di¡erent experi-
ments performed in triplicate.
3. Results
3.1. E⁄cient adenoviral gene transfer into macrophage cell line
RAW 264.7
We ¢rst determined the level of adenoviral-mediated over-
expression of Ref-1 in RAW 264.7 cells. Infection of cells with
AdRef-1 (50, 150, 300 MOI) showed signi¢cant expression of
Ref-1 compared to cells infected with AdDl312 (300 MOI) or
uninfected cells, in a MOI-dependent manner (Fig. 1).
3.2. Ref-1 inhibits NO synthesis in LPS-stimulated
macrophages
Next, we assessed the role of Ref-1 in regulating NO syn-
thesis of LPS-stimulated RAW 264.7 cells. Cells were infected
with AdDl312 or AdRef-1 as described in Section 2, and then
stimulated with 200 ng/ml LPS, the most notable activator for
NO synthesis in macrophages, for 24 h. The amount of NO
Fig. 1. Demonstration of adenoviral-mediated gene transfer in mac-
rophage cell line RAW 264.7. Cells were infected with AdDl312 or
AdRef-1, as indicated, at di¡erent MOIs for 16 h, and whole cell
extracts were analyzed by Western blotting using a Ref-1 antibody.
L-Actin was used as an internal control to monitor equal protein
loading.
Fig. 2. E¡ect of Ref-1 on the synthesis of NO by LPS-stimulated
macrophages. Cells were infected with AdDl312 (300 MOI) or
AdRef-1 (300 MOI) for 16 h. A: Measurement of nitrite. Unin-
fected, AdDl312- and AdRef-1-infected cells were incubated for an-
other 24 h either in a medium alone or in a medium that contained
LPS (200 ng/ml). Then, supernatants were collected, and the amount
of nitrite released by macrophages was measured by the method of
Griess. Results are presented as meansPS.D. of three independent
cell preparations. B: Fluorescence intensity by NO indicator. Cells
were infected and stimulated with LPS, as described in A. Then, the
cells were washed 12 h after stimulation, incubated for another 1 h
in KRP bu¡er containing DAF-2 in the presence or absence of
L-NAME (1 mM), as described in Section 2. Supernatants were mea-
sured with a £uorescence microplate reader. Values are meansPS.D.
of three experiments.
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released was measured by the method of Griess after conver-
sion to nitrite. As shown in Fig. 2A, LPS increased NO syn-
thesis in uninfected and AdDl312-infected macrophages.
However, AdRef-1-infected cells resulted in a signi¢cant de-
crease of NO release induced by LPS stimulation.
The ability of overexpressed Ref-1 to reduce intracellular
NO secreted to the medium was also evaluated in macro-
phages. The N-nitrosation of DAFs, yielding the highly green
£uorescent triazolo£uoresceins, o¡ers the advantages of spec-
i¢city, sensitivity, and a simple protocol for the direct detec-
tion of NO (detection limit 5 nM). As shown in Fig. 2B, there
was no signi¢cant di¡erence in £uorescent levels between un-
infected, AdDl312-infected, and AdRef-1-infected cells under
unstimulated conditions (6 5 WM). The supernatant of unin-
fected and AdDl312-infected macrophages stimulated with
LPS produced high £uorescent intensity upon incubation
with DAF-2. In comparison, cells infected with Ref-1 showed
signi¢cant reductions in LPS-induced £uorescence intensity,
indicating that overexpressed Ref-1 inhibits LPS-induced
NO synthesis in macrophages. And L-NAME, a known in-
hibitor of NOS, totally blocked the increase of £uorescence
intensity, as expected.
3.3. Ref-1 inhibits the synthesis of iNOS in LPS-stimulated
macrophages
To know the role of Ref-1 on the regulation of iNOS gene
expression, we analyzed the amount of expressed iNOS by
Western blot analysis (Fig. 3). In unstimulated AdDl312-in-
fected cells, iNOS was not detectable. And LPS induced ex-
pressed iNOS level in AdDl312-infected cells. However, when
AdRef-1-infected cells were stimulated with LPS, iNOS con-
tent was decreased MOI-dependently.
3.4. Ref-1 inhibits LPS-induced apoptosis in macrophages
To this end, Hoechst staining was conducted to determine
whether the Ref-1-mediated decrease of NO synthesis prevents
LPS-induced apoptosis. It was demonstrated that Ref-1 sig-
ni¢cantly reduced LPS-induced apoptosis, as determined by
nuclear morphology. When AdDl312-infected cells were
stimulated with LPS, the percentage of dead or dying cells
was highly increased (Fig. 4A), compared with the typical
round nuclei of unstimulated cells (Fig. 4B). This ¢nding sug-
gests that Ref-1 inhibits apoptosis via the reduction of NO
synthesis in LPS-stimulated macrophages.
4. Discussion
Excess NO released by iNOS reveals antimicrobial and tu-
moricidal e¡ects [1,18], but can also a¡ect the surrounding
tissue, suggesting a pathological role of NO for several in£am-
matory diseases [4,5,18]. And NO can induce apoptosis in
various cell types, including macrophages [19,20], L-cells
[21], and thymocytes [22]. NO induced accumulation of the
tumor suppressor protein p53, which was described as an
essential and early indicator of NO-induced apoptosis [23].
Subsequently, cleavage of poly(ADP-ribose) polymerase indi-
cating the activation of caspases or related proteases may
occur [24,25]. However, there may also be p53- and caspase-
independent pathways indicating that NO-induced apoptosis
more likely is the result of direct DNA damage [25^27].
This report provides evidence that overexpression of Ref-1
inhibits NO synthesis and NO-mediated apoptosis in LPS-
Fig. 3. E¡ect of Ref-1 on the expression of iNOS in macrophages.
Cells were infected with AdDl312 or AdRef-1, as indicated, and
stimulated with LPS (200 ng/ml) for another 24 h. Whole cell ex-
tracts were subjected to 10% SDS^PAGE and transferred to a nitro-
cellulose ¢lter.
Fig. 4. E¡ect of Ref-1 on NO-induced apoptosis in stimulated mac-
rophages. A: Measurement of cell apoptosis. Uninfected and in-
fected cells were stimulated with LPS (200 ng/ml) in the presence or
absence of L-NAME (1 mM) for 24 h. Cells were ¢xed and stained
with the Hoechst dye 33342. Images were obtained with a £uores-
cence microscope. Values are meansPS.D. of three independent ex-
periments. B: Hoechst staining pictures demonstrating nuclear con-
densation or fragmentation.
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stimulated macrophages. Ref-1 is described in the literature as
a nuclear protein, and would therefore not be predicted to
regulate cytoplasmic factors. However, Ref-1 is also expressed
in the cytoplasm of a variety of cell types, including endothe-
lial cells, hepatocytes, and thyroid cells [13,28,29]. Although
mitochondria play a key role in the regulation of apoptosis as
a predominant source of reactive oxygen species (ROS) gen-
erated in most apoptotic cells, the most important system for
ROS generation in phagocytes is NADPH oxidase [30,31].
The observation that Ref-1 modulates the activity of a
Rac1-regulated oxidase may also have relevance to immune
cell function. Rac proteins regulate the activity of the
NADPH oxidase that is responsible for the microbial oxida-
tive burst in macrophages and neutrophils. Furthermore, dif-
ferentiation of circulating monocytes to tissue macrophages is
associated with a shift of Ref-1 expression from the nucleus to
the cytoplasm [32,33] with a concomitant decrease in phorbol
ester-stimulated ROS generation [34], which suggests a role
for cytoplasmic Ref-1 in the regulation of the macrophage
oxidative burst.
These accumulated lines of evidence provide a functional
connection between inhibition of NO synthesis mediated by
NF-UB [35], which is the primary transcription factor regulat-
ing iNOS gene expression after LPS stimulation, and decrease
of intracellular ROS via the inhibition of NADPH oxidase in
the activation of macrophages. In fact, in knockout mice with
defective NADPH oxidase, LPS-induced NF-UB activation is
de¢cient, indicating the NADPH oxidase pathway is impor-
tant for maximal activation of NF-UB following treatment
with LPS [36]. Indeed, overexpression of Ref-1 attenuated
NF-UB activation in LPS-stimulated RAW 264.7 cells (data
not shown).
In conclusion, the results presented in this report demon-
strate that Ref-1 inhibits NO synthesis in LPS-stimulated
macrophage RAW 264.7 cells. The results also suggest that
the level of intracellular Ref-1 may negatively regulate NO-
mediated apoptosis of activated macrophages. Further studies
are needed to determine whether Ref-1 is involved in regula-
tion of iNOS in other cell types with iNOS. And this ¢nding
prompts future experiments of the underlying molecular
mechanisms in regulation of the induction of NO synthesis
and NO-mediated apoptosis in the development of activation
and death in macrophages.
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